Form 4: Decheng Capital Reduces Stake in BeyondSpring

Decheng Capital, a 10% owner and director, reported selling over 21,000 shares of BeyondSpring Inc. ordinary shares through pre-arranged trading plans.

Summary

• Decheng Capital China Life Sciences USD Fund III, L.P., a 10% owner and director of BeyondSpring Inc. (BYSI), reported the sale of 21,046 ordinary shares.
• The sales occurred over three days: 9,050 shares on September 9, 2025, 8,176 shares on September 10, 2025, and 3,820 shares on September 11, 2025.
• The shares were sold at weighted average prices ranging from $1.90 to $1.97 per share.
• These transactions were made pursuant to a Rule 10b5-1(c) trading plan, indicating pre-scheduled sales.
• Following these transactions, Decheng Capital China Life Sciences USD Fund III, L.P. indirectly holds 1,874,710 ordinary shares.
• Other related Decheng Capital entities, Decheng Capital China Life Sciences USD Fund II, L.P. and Decheng Capital Global Healthcare Fund (Master), LP, indirectly hold 1,617,409 and 891,734 ordinary shares, respectively.
• Dr. Xiangmin Cui is associated with the general partners of these funds and may be deemed to beneficially own the securities, disclaiming ownership except for his proportionate pecuniary interest therein.

Sentiment

Score: 4

Explanation: The sentiment is moderately negative due to significant insider selling by a 10% owner and director. While the 10b5-1 plan provides some mitigation, the reduction in stake by a knowledgeable party is generally perceived as a bearish signal for the stock.

Positives

• The sales were conducted under a Rule 10b5-1(c) trading plan, indicating pre-scheduled transactions rather than an immediate reaction to new, negative information.

Negatives

• A significant shareholder and director, Decheng Capital, reduced its stake in BeyondSpring Inc. by selling 21,046 ordinary shares.
• Insider selling, even under a 10b5-1 plan, can be perceived negatively by the market as it suggests a lack of conviction or a desire to diversify by a knowledgeable party.

Risks

• Increased selling pressure on BeyondSpring Inc.'s stock due to a large shareholder reducing its position.
• Potential negative market sentiment if investors interpret the insider selling as a signal of future underperformance, despite the 10b5-1 plan.

Future Outlook

NA

Management Comments

• The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.90 to $2.00 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
• Each of GP III and Dr. Cui disclaims beneficial ownership of these securities, except to the extent of its or his proportionate pecuniary interest therein.

Industry Context

Insider selling, particularly by a significant institutional investor and director in a biotechnology or life sciences company like BeyondSpring, can sometimes signal a shift in investment strategy or a re-evaluation of the company's near-term prospects. While the 10b5-1 plan mitigates the immediate negative interpretation, it's still a reduction in exposure by a knowledgeable party in a sector often sensitive to such signals.

Related Party Transactions

• The filing details the indirect beneficial ownership of shares by various Decheng Capital funds and their general partners, including Dr. Cui Xiangmin, who is a manager of these general partners and also a director/10% owner of BeyondSpring Inc. This structure inherently involves related parties.
• The reported sales are transactions by a related party (Decheng Capital funds) in the issuer's securities.

Stakeholder Impact

• Shareholders: May interpret the insider selling as a negative signal, potentially leading to decreased confidence and selling pressure on the stock.
• Management: Could face questions regarding the company's outlook if a significant investor is reducing its stake.
• Employees: No direct impact mentioned, but general market sentiment can indirectly affect employee morale or stock-based compensation value.

Key Dates

Recommendation

While the insider selling by Decheng Capital, a 10% owner and director, is a negative signal, the transactions were conducted under a pre-arranged 10b5-1 plan, which suggests the decision to sell was made in advance and not necessarily based on new, immediate negative information. Given the limited information in a Form 4, a 'hold' recommendation is appropriate to observe further developments and assess the broader context of the company's performance and strategic direction, rather than reacting solely to this insider transaction.

Keywords

BeyondSpring Inc., BYSI, Decheng Capital, insider selling, Form 4, beneficial ownership, ordinary shares, 10b5-1 plan, director selling, 10% owner